Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy | CYTK Stock News
autoimmune diseases Archives - DelveInsight
Novartis in advanced talks to buy Cytokinetics- source | Reuters
Cytokinetics and The ALS Association Announce Release of
Endpoints News — Cytokinetics reports an ALS fail; Texas biotech lays off 100+ employees
The clock is ticking, and Cytokinetics is running out of December : r/biotech
Cytokinetics on LinkedIn: We're proud to announce the publication of preclinical data on fast…
Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
Investor Overview | Cytokinetics, Inc.
Buy Cytokinetics | Lightyear
Cytokinetics Announces Three Upcoming Presentations at the American College of Cardiology 72nd Annual Scientific Session | Cytokinetics, Inc.
Cytokinetics calls for proposals for Communications Grant Program | $20K grant will go to help ALS patient advocacy group | ALS News Today
Investor Overview | Cytokinetics, Inc.
Morgan Stanley Downgrades Cytokinetics (CYTK)
Investor Overview | Cytokinetics, Inc.
Cytokinetics leaps on heart drug aficamten trial success
Cytokinetics Awards $20K Communications Grants to 2 ALS Groups | NEALS, ALS Association Chapter Among 5 Selected | ALS News Today
Cure SMA and Cytokinetics Announce Partnership to Advance Education and Awareness of Spinal Muscular Atrophy - Cure SMA
:max_bytes(150000):strip_icc()/GettyImages-1290196714-c8509605980b4c01a74f837e43331439.jpg "Cytokinetics Stock Skyrockets on Positive Results from Study of Its Heart Drug")
Cytokinetics Stock Skyrockets on Positive Results from Study of Its Heart Drug
Cytokinetics Announces Positive Results From SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy | Cytokinetics, Inc.
Amgen Emerges as Potential Cytokinetics Suitor as Novartis Pulls Away: Reports | BioSpace
Cytokinetics (CYTK) Shares Whipsaw Amid Deal Speculation - Bloomberg
SEC Filing | Cytokinetics, Inc.
Cytokinetics hopes to resurrect omecamtiv | Evaluate
